Session Name: Update in Donor Derived Infections in Solid Organ Transplant Patients 

Time: April 8, 2026

We appreciate your time and effort in participating in this CME Sessional Evaluation. This evaluation is a pipeline to bring your voice to the leadership, instructors, and CME team. We value your voice and try our best to improve the quality of future activities.

*
*
Did/Will you use this information for specific patient(s)?
What patient/health care problem recently challenged you, and you wish you knew more about?
Comments and Feedback on the learning experience, content, procedure, and instructors, etc. in this session.
As a result of my participation in this activity, I am better able to... 4 - Strongly Agree 3- Agree 2 - Somewhat Disagree 1- Strongly disagree
1234
Define different types of donor derived infections and risk factors for donor derived infections Expected (CMV, EBV, Hepatitis B, Hepatitis C) vs Unexpected (Rabies, Tuberculosis, Strongyloides)
Determine the role of Transplant ID physicians in risk assessment of potential donors to prevent or manage donor derived infections (content will be related to risk of rejecting a needed organ vs accepting some risk of infection, whether the infection is treatable or controlled in the donor etc). .
Recognize when to consider an unexpected donor derived infection in the differential diagnosis of a transplant patient (timeline of infections after transplant, how to investigate donor and other recipients from that donor using UNOS).
The following speaker(s) demonstrated experiential knowledge of the topic 4 - Strongly Agree 3- Agree 2 - Somewhat Disagree 1- Strongly Disagree
1234
Anna Corey, MD
Choose the option that best fits your evaluation of this activity: 4 - Strongly Agree 3- Agree 2 - Somewhat Disagree 1- Strongly Disagree
1234
The content provided a fair and balanced coverage of the topic
The content was free of commercial bias